Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HYLO (sodium hyaluronate)
- Development stage
- Unknown
- Lead developer
- URSAPHARM Arzneimittel
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
HYLO is a range of preservative-free ophthalmic lubricants designed for the treatment of dry eye syndrome and ocular surface irritation. The core active ingredient is sodium hyaluronate, a naturally occurring, high-molecular-weight polysaccharide with high viscoelastic properties. When applied topically, it forms a stable, long-lasting moisture film on the eye's surface that stabilizes the tear film and protects the cornea from desiccation. Developed by Ursapharm Arzneimittel, the HYLO series utilizes the patented COMOD (COntinuous MOnoDose) system, a sophisticated airless delivery mechanism that maintains the sterility of the solution for up to six months after opening without the need for chemical preservatives. The product line includes various formulations tailored to different severities of dry eye, such as HYLO-COMOD (0.1% concentration) and HYLO-GEL (0.2% concentration for severe cases).
- Brand names
- HYLOHYLO-COMODHYLO-GELHYLO-DUALHYLO-FRESHHYLO-PARINHYLO-CARE
- Other names
- hyaluronic acid sodium salt
02
Targets
CD44 (CD44 antigen)
Beyond the preview
Go deeper on HYLO (sodium hyaluronate).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HYLO (sodium hyaluronate).